Anti-HGFR / c-Met Reference Antibody (telisotuzumab vedotin), IgG1

Product Overview

• Article Name: Anti-HGFR / c-Met Reference Antibody (telisotuzumab vedotin), IgG1
• Biozol Catalog Number: SYB-CHB249
• Supplier Catalog Number: CHB249
• Alternative Catalog Number: SYB-CHB249-100UG,SYB-CHB249-1MG
• Manufacturer: Sanyou Bio
• Category: Antikörper
• Application: ELISA, FA, FACS, Kinetics
• Species Reactivity: Human
• Alternative Names: ABBV-399

Product Description

Telisotuzumab vedotin is an ADC consisting of a cMET-directed antibody and Monomethyl auristatin E (MMAE) that has recently obtained the breakthrough therapy designation (BTD) for the treatment of patients with c-Met overexpression, advanced/metastatic wild-type (WT) epithelial growth factor receptor (EGFR) non-squamous non-small cell lung cancer (sqNSCLC) that progressed during or after platinum-based chemotherapy.

Product Properties

• Concentration: 1mg/ml
• Molecular Weight: 151.37 kDa
• Isotype: IgG1
• NCBI: 08581
• UniProt: P08581
• Buffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Purity: >90%
• Form: Lyophilize
• Target: HGFR / c-Met